Histone H2A.J: A Potential Drug Target and Biomarker (G55766)
Histone H2A.J: A Potential Drug Target and Biomarker
Histones are a type of protein that plays a critical role in the regulation of gene expression and cell development. The histone proteins are composed of four subunits: H1, H2A, H2B, and H3. H2A.J, a specific subunit of the histone H2A protein, is a potential drug target and biomarker for several diseases.
The histone H2A.J protein is composed of 110 amino acid residues and has a molecular weight of 13.9 kDa. It is a key component of the histone complex, which is a protein-protein interaction network that plays a critical role in regulating gene expression and cell development. The histone H2A.J protein is involved in the regulation of cell adhesion, migration, and the association with signaling pathways that are involved in cancer progression.
H2A.J is a G-protein-coupled receptor (GPCR), which means it is a transmembrane protein that is involved in the regulation of intracellular signaling pathways. GPCR signaling pathways are involved in the regulation of cellular processes such as cell adhesion, migration, and angiogenesis. The H2A.J protein is involved in the regulation of several signaling pathways, including the TGF-β pathway, the FGF pathway, and the Wnt pathway.
The TGF-β pathway is involved in the regulation of cell growth, differentiation, and inflammation. The H2A.J protein is involved in the regulation of the TGF-β pathway by interacting with the transcription factor, SMAD. The SMAD protein is a negative regulator of the TGF-β pathway, and the H2A.J protein is involved in the regulation of the SMAD protein to enhance its positive function in the pathway.
The FGF pathway is involved in the regulation of cell growth, differentiation, and tissue repair. The H2A.J protein is involved in the regulation of the FGF pathway by interacting with the transcription factor, FGFR1. The FGFR1 protein is a receptor for the FGF signaling pathway, and the H2A.J protein is involved in the regulation of FGFR1 to enhance its positive function in the pathway.
The Wnt pathway is involved in the regulation of cell growth, differentiation, and development. The H2A.J protein is involved in the regulation of the Wnt pathway by interacting with the transcription factor, Wnt1. The Wnt1 protein is a receptor for the Wnt signaling pathway, and the H2A.J protein is involved in the regulation of Wnt1 to enhance its positive function in the pathway.
The H2A.J protein is also involved in the regulation of several signaling pathways that are involved in cancer progression. The H2A.J protein is involved in the regulation of the PI3K/Akt signaling pathway, which is involved in the regulation of cell survival and angiogenesis. The H2A.J protein is also involved in the regulation of the T-cell receptor (TCR) signaling pathway, which is involved in the regulation of cell immunity.
In conclusion, the histone H2A.J protein is a potential drug target and biomarker for several diseases. The H2A.J protein is involved in the regulation of several signaling pathways that are involved in cell growth, differentiation, and development. The H2A.J protein is also involved in the regulation of cancer progression, and it is a GPCR protein that can be targeted by small molecules. Further research is needed to understand the full role of the H2A.J protein in the regulation of cellular processes and the development of cancer.
Protein Name: H2A.J Histone
Functions: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling
The "H2AJ Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H2AJ comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
H2AP | H2AX | H2AZ1 | H2AZ1-DT | H2AZ2 | H2AZ2-DT | H2AZP2 | H2BC1 | H2BC10 | H2BC11 | H2BC12 | H2BC12L | H2BC13 | H2BC14 | H2BC15 | H2BC17 | H2BC18 | H2BC20P | H2BC21 | H2BC26 | H2BC27P | H2BC3 | H2BC4 | H2BC5 | H2BC6 | H2BC7 | H2BC8 | H2BC9 | H2BP1 | H2BP2 | H2BP3 | H2BW1 | H2BW2 | H2BW4P | H3-3A | H3-3B | H3-4 | H3-5 | H3-7 | H3C1 | H3C10 | H3C11 | H3C12 | H3C13 | H3C14 | H3C15 | H3C2 | H3C3 | H3C4 | H3C6 | H3C7 | H3C8 | H3P16 | H3P36 | H3P37 | H3P44 | H3P5 | H3P6 | H4C1 | H4C11 | H4C12 | H4C13 | H4C14 | H4C15 | H4C16 | H4C2 | H4C3 | H4C4 | H4C5 | H4C6 | H4C7 | H4C8 | H4C9 | H6PD | HAAO | HABP2 | HABP4 | HACD1 | HACD2 | HACD3 | HACD4 | HACE1 | HACL1 | HADH | HADHA | HADHAP1 | HADHB | HAFML | HAGH | HAGHL | HAGLR | HAGLROS | HAL | HAMP | HAND1 | HAND2 | HAND2-AS1 | HAO1 | HAO2 | HAO2-IT1
